Lipid-lowering medications: Fibrates

25,536views

Lipid-lowering medications: Fibrates

1H Exam

1H Exam

Bones of the lower limb
Anatomy of the anterior and medial thigh
Vessels and nerves of the gluteal region and posterior thigh
Anatomy of the leg
Anatomy of the hip joint
Fascia, vessels and nerves of the lower limb
Muscles of the gluteal region and posterior thigh
Anatomy of the knee joint
Joints of the ankle and foot
Bones of the upper limb
Anatomy of the brachial plexus
Anatomy of the arm
Vessels and nerves of the forearm
Anatomy of the elbow joint
Anatomy of the sternoclavicular and acromioclavicular joints
Joints of the wrist and hand
Fascia, vessels and nerves of the upper limb
Anatomy of the pectoral and scapular regions
Muscles of the forearm
Anatomy of the glenohumeral joint
Anatomy of the radioulnar joints
Anatomy clinical correlates: Axilla
Anatomy clinical correlates: Clavicle and shoulder
Anatomy clinical correlates: Arm, elbow and forearm
Anatomy clinical correlates: Median, ulnar and radial nerves
Glycolysis
Citric acid cycle
Electron transport chain and oxidative phosphorylation
Gluconeogenesis
Glycogen metabolism
Pentose phosphate pathway
Physiological changes during exercise
Amino acid metabolism
Nitrogen and urea cycle
Fatty acid synthesis
Fatty acid oxidation
Ketone body metabolism
Cholesterol metabolism
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Lactose intolerance
Pyruvate dehydrogenase deficiency
Familial hypercholesterolemia
Hyperlipidemia
Hypertriglyceridemia
Dyslipidemias: Pathology review
Disorders of fatty acid metabolism: Pathology review
Carbohydrates and sugars
Fats and lipids
Proteins
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Study designs
Cohort study
Clinical trials
Randomized control trial
Case-control study
Cytoskeleton and intracellular motility
Cell membrane
Extracellular matrix
Endocytosis and exocytosis
Resting membrane potential
Nuclear structure
Transcription of DNA
Gene regulation
Amino acids and protein folding
Cell cycle
DNA mutations
DNA replication
DNA damage and repair
Mitosis and meiosis
DNA structure
Translation of mRNA
Human development days 1-4
Human development week 2
Human development days 4-7
Human development week 3
Ectoderm
Endoderm
Mesoderm
Cardiac muscle histology
Artery and vein histology
Pancreas histology
Liver histology
Blood histology
Skin histology
Skeletal muscle histology
Central nervous system histology
Peripheral nervous system histology
Bacterial structure and functions
Ischemia
Necrosis and apoptosis
Hypoxia
Hyperplasia and hypertrophy
Atrophy, aplasia, and hypoplasia
Inflammation
Wound healing
Arterial disease
Hypertension
Deep vein thrombosis
Shock
Shock: Pathology review
Hypertension: Pathology review
Diabetes mellitus
Diabetic retinopathy
Diabetic nephropathy
Diabetes mellitus: Pathology review
Non-alcoholic fatty liver disease
Vitamin B12 deficiency
Microcytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Macrocytic anemia: Pathology review
Myasthenia gravis
Sunburn
Burns
Skin cancer
Skin cancer: Pathology review
Hyponatremia
Introduction to pharmacology
Enzyme function
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacodynamics: Desensitization and tolerance
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Cardiovascular system anatomy and physiology
Cardiac excitation-contraction coupling
Baroreceptors
Chemoreceptors
Renin-angiotensin-aldosterone system
Endocrine system anatomy and physiology
Hunger and satiety
Antidiuretic hormone
Insulin
Glucagon
Somatostatin
Cortisol
Pancreatic secretion
Blood components
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Introduction to the immune system
Cytokines
Innate immune system
Complement system
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Somatic hypermutation and affinity maturation
VDJ rearrangement
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Anergy, exhaustion, and clonal deletion
Vaccinations
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Skin anatomy and physiology
Muscular system anatomy and physiology
Brachial plexus
Neuromuscular junction and motor unit
Sliding filament model of muscle contraction
Slow twitch and fast twitch muscle fibers
Muscle contraction
Nervous system anatomy and physiology
Neuron action potential
Ascending and descending spinal tracts
Spinal cord reflexes
Motor cortex
Somatosensory pathways
Sympathetic nervous system
Parasympathetic nervous system
Adrenergic receptors
Cholinergic receptors
Pyramidal and extrapyramidal tracts
Body temperature regulation (thermoregulation)
Hydration
Movement of water between body compartments
Osmoregulation
Physiologic pH and buffers
Acid-base map and compensatory mechanisms
Buffering and Henderson-Hasselbalch equation
Respiratory acidosis
Pulmonary changes at high altitude and altitude sickness
Pulmonary changes during exercise
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Carbon dioxide transport in blood
Respiratory alkalosis
Metabolic alkalosis
The role of the kidney in acid-base balance
Anorexia nervosa
Eating disorders: Clinical
Muscle weakness: Clinical
Diabetes mellitus: Clinical
Insulins
Hypoglycemics: Insulin secretagogues

Transcript

Watch video only

Content Reviewers

Fibrates are a group of lipid-lowering medications, along with statins and niacin.

These medications are very effective at lowering triglyceride levels in the blood, but are less effective at controlling cholesterol.

Now, triglycerides make up most of your body fat, and they consist of a glycerol and 3 fatty acids.

So when we eat a box of chili fries, the fatty acids and cholesterol are absorbed into the cells in the small intestine.

The fatty acids are then converted into triglycerides.

However, triglycerides and cholesterol are not water soluble, so they can’t travel freely in the blood. To fix this, our body makes “shipping boxes” called lipoproteins.

These containers consist of a shell made of phospholipids and protein tags that act as instructions for their destination.

So after absorption, the small intestinal cells package the triglycerides and cholesterol into the largest, but least dense lipoproteins, called chylomicrons.

These are released into the lymphatic system and then enter the bloodstream via the subclavian vein. Then, they travel through the blood to reach the liver and other tissues in the body.

Now in the blood vessels near these tissues, we have an enzyme called lipoprotein lipase, which can break down triglycerides into fatty acids.

Cells in the nearby tissue can then use these fatty acids to generate ATP.

Adipose tissue can synthesize a lot of lipoprotein lipases, which means they have access to a lot of fatty acids.

Now, instead of using the fatty acids for energy, they pick them up, convert them back into triglycerides, and store them for later use.

Okay, so we can also synthesize fatty acids from glucose in the liver which are then converted into triglycerides.

These triglycerides and some cholesterol are packed into the next kind of lipoproteins called very-low-density lipoproteins or VLDL, which are smaller and more dense than chylomicrons.

This package is sent into the bloodstream to carry the energy-rich triglycerides to the rest of the body.

Now, lipoprotein lipases in the blood vessels will once again convert the triglycerides in the VLDLs into fatty acids, which can enter the cells; and the leftover VLDLs are called VLDL remnants.

This and the remaining cholesterol are converted into a new kind of lipoprotein, called a low-density lipoprotein, or LDL, which are even smaller and more dense than VLDL.

These will travel around the bloodstream and deliver cholesterol to cells in the rest of the body.

The final lipoprotein is the HDL, or high-density lipoprotein, which are smaller and denser than LDLs.

These are like the boxes you get when you try to return an item you bought online.

In this case, the liver produces HDL and releases them into the blood, where they pick up excess cholesterol from the peripheral tissues and brings them back to the liver.

So in essence, it’s the opposite of LDL, which carries cholesterol from the liver to the peripheral tissues.

Now, triglycerides are atherogenic which means they can cause atherosclerosis, increasing the risk of cardiovascular complications like strokes and myocardial infarctions.

Extremely high triglyceride levels can also lead to acute pancreatitis.

Okay, so if we want to lower triglyceride levels we can use a class of medications called fibrates.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "PPAR Agonists and Metabolic Syndrome: An Established Role?" International Journal of Molecular Sciences (2018)
  5. "Fibrates for primary prevention of cardiovascular disease events" Cochrane Database of Systematic Reviews (2016)
  6. "PPAR-Induced Fatty Acid Oxidation in T Cells Increases the Number of Tumor-Reactive CD8+ T Cells and Facilitates Anti–PD-1 Therapy" Cancer Immunology Research (2018)
  7. "Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study" BMJ (2019)